Stroli – the shopping trolley reimagined for modern needs. The shopping trolley, often associated with a particular image, is an untapped category ready for innovation. The market is flooded with generic, budget-friendly options that lack charm, with the exception of Rolser, which is pricier and claims the green niche. Stroli steps in as the go-to brand, offering a unique approach, positioning, voice, and eco-friendly credentials. Say goodbye to sore hands and plastic bags – Stroli makes shopping a pleasure with its high-quality, stylish trolley bags designed to enhance your convenience and style
days to go:
Extended
investment:
Withheld
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
Active Food Systems, trading as Synergy Grill, has developed and patented innovative and commercial cooking technology for the food and hospitality industry. Its ‘Fat Atomising Grill' makes cleaning quick and easy while delivering cost savings through a 59% reduction in fuel consumption. The company has sold 2000+ units of the grill to entities like Whitbread, Greene King, Marriott, Radisson and Marstons among others. Synergy Grill asserts that its performance in the first half of the year has been profitable despite COVID-19. They have contracts with reputed organisations like Whitbread and Marstons have generated revenues of £970,000. The company is in conversation with over 50 pubs and restaurants including product trials with Nandos, Weatherspoons and Mitchell Butler that are interested in its product. It will use the investment to grow its business across different verticals.
days to go:
Expired
investment:
£316,488
Garbanzo Snacks is a profitable businesses, currently selling their chickpeas with a sprinkling of flavour in 725 Holland and Barrett stores. They use 100% chickpeas with minimal processing, this keeps the products as pure and unadulterated as possible.
days to go:
Expired
investment:
Withheld
EarlyBird have created a number of different healthy snack packs, all made with fresh ingredients. EarlyBird deliver their snacks straight to your door meaning you don't have to leave the comfort of your home.
days to go:
Expired
investment:
£168,000
Sense Products is a food supplement company that currently have 5 products on the market; Sense for a night out (alcohol), Sense for nicotine lovers (smokers), Sense for cholesterol, Sense for city living (busy lives) and Sense for weight warriors.
days to go:
Expired
investment:
£200,000
Hemspan states that it designs bio-based building systems and products for construction by combining modern methods, technology and hemp to produce net-zero carbon solutions. The company argues that every time an average house is built, the CO2 emitted by the manufacture, transport and assembly of the materials used is around 50 to 60 tonnes. Hemspan says that one hectare of UK-grown industrial hemp can absorb 11 tonnes of CO2 each year with regeneratively farmed hemp capable of sequestering a further 6 tonnes per hectare of CO2 into the soil each year. Hemspan intends to activate significant demand for hemp farming in the UK and develop processing technologies to reduce reliance on imports and enable large scale manufacturing of bio-based cladding and insulation products that spin out of R&D programmes. It asserts that the global industrial hemp market is expected to grow at 25% CAGR reaching US$ 27 billion by 2028. It aims to be a contender in this segment.
days to go:
Expired
investment:
£200,000
Metal matrix composite components and materials, primarily comprised of aluminium for use in the engineering and manufacturing industries. Alvant specialise in designing, developing and producing the composite for well-known clients such as Ford and Safran.
In the last financial year, Alvant achieved a turnover of almost £617k and has invested more than £10m towards manufacturing and testing their own product. Alvant is now raising funds to distribute their components to a wider market and expand the number of commercial applications that would benefit from their materials.
days to go:
Expired
investment:
£2,105,001
